PHBA Stock Overview
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
Sonova Holding AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CHF51.00 |
| 52 Week High | CHF61.00 |
| 52 Week Low | CHF42.60 |
| Beta | 0.98 |
| 1 Month Change | -0.97% |
| 3 Month Change | -15.00% |
| 1 Year Change | -8.93% |
| 3 Year Change | 5.37% |
| 5 Year Change | 43.26% |
| Change since IPO | 106.90% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHBA | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | 2.1% | 0.5% |
| 1Y | -8.9% | -8.4% | 1.3% |
Return vs Industry: PHBA underperformed the German Medical Equipment industry which returned -7.7% over the past year.
Return vs Market: PHBA underperformed the German Market which returned 2.3% over the past year.
Price Volatility
| PHBA volatility | |
|---|---|
| PHBA Average Weekly Movement | 4.4% |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: PHBA has not had significant price volatility in the past 3 months.
Volatility Over Time: PHBA's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1947 | 17,636 | Arnd Kaldowski | www.sonova.com |
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.
Sonova Holding AG Fundamentals Summary
| PHBA fundamental statistics | |
|---|---|
| Market cap | €15.34b |
| Earnings (TTM) | €613.61m |
| Revenue (TTM) | €3.72b |
25.0x
P/E Ratio4.1x
P/S RatioIs PHBA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHBA income statement (TTM) | |
|---|---|
| Revenue | CHF3.64b |
| Cost of Revenue | CHF1.03b |
| Gross Profit | CHF2.62b |
| Other Expenses | CHF2.02b |
| Earnings | CHF600.50m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
May 14, 2024
| Earnings per share (EPS) | 10.07 |
| Gross Margin | 71.78% |
| Net Profit Margin | 16.48% |
| Debt/Equity Ratio | 74.2% |
How did PHBA perform over the long term?
See historical performance and comparison